SGMT vs. PRCT

Last updated Apr 1, 2026

Compare and contrast key facts about Sagimet Biosciences Inc. (SGMT) and PROCEPT BioRobotics Corporation (PRCT).

Performance

SGMT vs. PRCT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sagimet Biosciences Inc. (SGMT) and PROCEPT BioRobotics Corporation (PRCT). The values are adjusted to include any dividend payments, if applicable.

SGMT vs. PRCT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
SGMT Sagimet Biosciences Inc.	-11.74%	31.56%	-16.97%	-66.02%
PRCT PROCEPT BioRobotics Corporation	-20.50%	-60.93%	92.13%	14.82%

Fundamentals

EPS SGMT : -$1.58 PRCT : -$2.58
Total Revenue (TTM) SGMT : $0.00 PRCT : $308.05M
Gross Profit (TTM) SGMT : $0.00 PRCT : $196.23M
EBITDA (TTM) SGMT : -$56.89M PRCT : -$89.40M

Returns By Period

In the year-to-date period, SGMT achieves a -11.74% return, which is significantly higher than PRCT's -20.50% return.

SGMT

• 1D: 14.84%
• 1M: -8.49%
• YTD: -11.74%
• 6M: -23.83%
• 1Y: 60.28%
• 3Y*: —
• 5Y*: —
• 10Y*: —

PRCT

• 1D: -2.11%
• 1M: 10.22%
• YTD: -20.50%
• 6M: -29.92%
• 1Y: -57.07%
• 3Y*: -4.15%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SGMT vs. PRCT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SGMT

SGMT Risk / Return Rank: 63
SGMT Sharpe Ratio Rank: 62
SGMT Sortino Ratio Rank: 72
SGMT Omega Ratio Rank: 66
SGMT Calmar Ratio Rank: 58
SGMT Martin Ratio Rank: 55

PRCT

PRCT Risk / Return Rank: 7
PRCT Sharpe Ratio Rank: 5
PRCT Sortino Ratio Rank: 5
PRCT Omega Ratio Rank: 7
PRCT Calmar Ratio Rank: 8
PRCT Martin Ratio Rank: 12

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SGMT vs. PRCT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sagimet Biosciences Inc. (SGMT) and PROCEPT BioRobotics Corporation (PRCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SGMT	PRCT	Difference
Sharpe ratio Return per unit of total volatility	0.58	-0.97	+1.56
Sortino ratio Return per unit of downside risk	1.68	-1.61	+3.29
Omega ratio Gain probability vs. loss probability	1.19	0.82	+0.37
Calmar ratio Return relative to maximum drawdown	0.73	-0.90	+1.63
Martin ratio Return relative to average drawdown	1.31	-1.42	+2.73
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SGMT vs. PRCT - Sharpe Ratio Comparison

The current SGMT Sharpe Ratio is 0.58, which is higher than the PRCT Sharpe Ratio of -0.97. The chart below compares the historical Sharpe Ratios of SGMT and PRCT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	SGMT	PRCT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.58	-0.97	+1.56
Sharpe Ratio (All Time) Calculated using the full available price history	-0.22	-0.17	-0.05

Correlation

The correlation between SGMT and PRCT is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SGMT vs. PRCT - Dividend Comparison

Neither SGMT nor PRCT has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

SGMT vs. PRCT - Drawdown Comparison

The maximum SGMT drawdown since its inception was -89.69%, which is greater than PRCT's maximum drawdown of -77.18%. Use the drawdown chart below to compare losses from any high point for SGMT and PRCT.

Drawdown Indicators

	SGMT	PRCT	Difference
Max Drawdown Largest peak-to-trough decline	-89.69%	-77.18%	-12.51%
Max Drawdown (1Y) Largest decline over 1 year	-55.57%	-65.12%	+9.55%
Current Drawdown Current decline from peak	-71.63%	-74.85%	+3.22%
Average Drawdown Average peak-to-trough decline	-66.14%	-30.01%	-36.13%
Ulcer Index Depth and duration of drawdowns from previous peaks	31.28%	40.98%	-9.70%

Volatility

SGMT vs. PRCT - Volatility Comparison

Sagimet Biosciences Inc. (SGMT) has a higher volatility of 24.17% compared to PROCEPT BioRobotics Corporation (PRCT) at 21.09%. This indicates that SGMT's price experiences larger fluctuations and is considered to be riskier than PRCT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SGMT	PRCT	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.17%	21.09%	+3.08%
Volatility (6M) Calculated over the trailing 6-month period	58.18%	44.70%	+13.48%
Volatility (1Y) Calculated over the trailing 1-year period	104.56%	58.84%	+45.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	153.77%	64.84%	+88.93%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	153.77%	64.84%	+88.93%

Financials